You need to enable JavaScript to run this app.
Stakeholders seek changes to FDA’s oncology multiregional trial guideline
Regulatory News
Ferdous Al-Faruque
Guidance
Pharmaceuticals
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)